These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 21620966)
21. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression. Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879 [TBL] [Abstract][Full Text] [Related]
22. Regulator of G-protein signalling and GoLoco proteins suppress TRPC4 channel function via acting at Gαi/o. Jeon JP; Thakur DP; Tian JB; So I; Zhu MX Biochem J; 2016 May; 473(10):1379-90. PubMed ID: 26987813 [TBL] [Abstract][Full Text] [Related]
23. Structural motifs in the RGS RZ subfamily combine to attenuate interactions with Gα subunits. Salem-Mansour D; Asli A; Avital-Shacham M; Kosloff M Biochem Biophys Res Commun; 2018 Sep; 503(4):2736-2741. PubMed ID: 30111488 [TBL] [Abstract][Full Text] [Related]
24. Development of a bimolecular luminescence complementation assay for RGS: G protein interactions in cells. Bodle CR; Hayes MP; O'Brien JB; Roman DL Anal Biochem; 2017 Apr; 522():10-17. PubMed ID: 28115169 [TBL] [Abstract][Full Text] [Related]
25. Interleukin-6 inhibits cell proliferation in a rat model of hepatocellular carcinoma. Moran DM; Mayes N; Koniaris LG; Cahill PA; McKillop IH Liver Int; 2005 Apr; 25(2):445-57. PubMed ID: 15780071 [TBL] [Abstract][Full Text] [Related]
26. Differential contribution of GTPase activation and effector antagonism to the inhibitory effect of RGS proteins on Gq-mediated signaling in vivo. Anger T; Zhang W; Mende U J Biol Chem; 2004 Feb; 279(6):3906-15. PubMed ID: 14630933 [TBL] [Abstract][Full Text] [Related]
27. Development of a novel high-throughput screen and identification of small-molecule inhibitors of the Gα-RGS17 protein-protein interaction using AlphaScreen. Mackie DI; Roman DL J Biomol Screen; 2011 Sep; 16(8):869-77. PubMed ID: 21680864 [TBL] [Abstract][Full Text] [Related]
28. Interplay between negative and positive design elements in Gα helical domains of G proteins determines interaction specificity toward RGS2. Kasom M; Gharra S; Sadiya I; Avital-Shacham M; Kosloff M Biochem J; 2018 Jul; 475(14):2293-2304. PubMed ID: 29925530 [TBL] [Abstract][Full Text] [Related]
29. CCK activates RhoA and Rac1 differentially through Galpha13 and Galphaq in mouse pancreatic acini. Sabbatini ME; Bi Y; Ji B; Ernst SA; Williams JA Am J Physiol Cell Physiol; 2010 Mar; 298(3):C592-601. PubMed ID: 19940064 [TBL] [Abstract][Full Text] [Related]
31. Selective loss of fine tuning of Gq/11 signaling by RGS2 protein exacerbates cardiomyocyte hypertrophy. Zhang W; Anger T; Su J; Hao J; Xu X; Zhu M; Gach A; Cui L; Liao R; Mende U J Biol Chem; 2006 Mar; 281(9):5811-20. PubMed ID: 16380388 [TBL] [Abstract][Full Text] [Related]
32. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype. Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759 [TBL] [Abstract][Full Text] [Related]
33. Vitamin D and dexamethasone inversely regulate parathyroid hormone-induced regulator of G protein signaling-2 expression in osteoblast-like cells. Hömme M; Schmitt CP; Himmele R; Hoffmann GF; Mehls O; Schaefer F Endocrinology; 2003 Jun; 144(6):2496-504. PubMed ID: 12746312 [TBL] [Abstract][Full Text] [Related]
34. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells. Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525 [TBL] [Abstract][Full Text] [Related]
35. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells. Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068 [TBL] [Abstract][Full Text] [Related]
36. RGS14, a GTPase-activating protein for Gialpha, attenuates Gialpha- and G13alpha-mediated signaling pathways. Cho H; Kozasa T; Takekoshi K; De Gunzburg J; Kehrl JH Mol Pharmacol; 2000 Sep; 58(3):569-76. PubMed ID: 10953050 [TBL] [Abstract][Full Text] [Related]
37. The down-regulation of GNAO1 and its promoting role in hepatocellular carcinoma. Pei X; Zhang J; Wu L; Lü B; Zhang X; Yang D; Liu J Biosci Rep; 2013 Sep; 33(5):. PubMed ID: 23984917 [TBL] [Abstract][Full Text] [Related]
38. RGS-insensitive G-protein mutations to study the role of endogenous RGS proteins. Fu Y; Zhong H; Nanamori M; Mortensen RM; Huang X; Lan K; Neubig RR Methods Enzymol; 2004; 389():229-43. PubMed ID: 15313569 [TBL] [Abstract][Full Text] [Related]
39. RGS17: an emerging therapeutic target for lung and prostate cancers. Bodle CR; Mackie DI; Roman DL Future Med Chem; 2013 Jun; 5(9):995-1007. PubMed ID: 23734683 [TBL] [Abstract][Full Text] [Related]
40. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models. Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]